Keywords: COPD; Chronic respiratory disease; Stable cardiac disease; Spirometry; SGRQ;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Electrical stimulation; Exercise; Physiotherapy techniques; Pulmonary disease, chronic obstructive; Rehabilitation; BMI; body mass index; COPD; chronic obstructive pulmonary disease; CPET; cardiopulmonary exercise testing; NMES; neuromuscular electrical s
Metabolomic profiling of doxycycline treatment in chronic obstructive pulmonary disease
Keywords: COPD; chronic obstructive pulmonary disease; WHO; World health organization; FEV1; forced expiratory volume in 1Â s; FVC; forced vital capacity; CAT; COPD Assessment Test; SGRQ; St George's respiratory questionnaire; MMP; matrix metalloproteases; NMR; n
Keywords: ISWT; incremental shuttle walk test; SGRQ; St George׳s Respiratory Questionnaire; Chronic obstructive pulmonary disease; Exercise test; Incremental shuttle walk test; Health status; Respiratory function tests;
Keywords: COPD; chronic obstructive pulmonary disease; LABA; long acting beta-2-agonists; LAMA; long acting muscarinic antagonists; EBV; endobronchial valves; EBC; endobronchial coils; FEV1; forced expiratory flow in 1Â s; FVC; forced vital capacity; IC; inspirator
Keywords: meta-analysis; nontuberculous mycobacteria; systematic review; treatment outcome; 6MWT; 6-min walk test; AMX; amikacin; ATS; American Thoracic Society; AZT; azithromycin; BTS; British Thoracic Society; CLARI; clarithromycin; IDSA; Infectious Diseases Soci
Keywords: autophagy; FEV1; lymphangioleiomyomatosis; sirolimus; VEGF-D; 6-MWD; 6-min walk distance; AML; angiomyolipoma; Dlco; diffusion coefficient for carbon monoxide; DLT; dose-limiting toxicity; LAM; lymphangioleiomyomatosis; MTD; maximal tolerated dose; NCI; N
Keywords: Emphysema severity measure; local histogram analysis; LAA%; percent low attenuation areas; COPD; chronic obstructive pulmonary disease; FEV1; forced expiratory volume in 1 second; CT; computed tomography; SGRQ; St. George's Respiratory Questionnaire; 2D;
Keywords: health-related quality of life; Hispanic; quality of life; racial disparities; smokers; smoking; SQRQ; HRQL; health-related quality of life; NHW; non-Hispanic white; SF-36; Medical Outcomes 36-item Short Form Health Survey; SGRQ; St. George's Respirator
Keywords: connective tissue disease; hypersensitivity pneumonia; idiopathic interstitial pneumonia; idiopathic pulmonary fibrosis; interstitial lung disease; cHP; chronic hypersensitivity pneumonitis; CTD-ILD; connective tissue disease-related ILD; Dlco; diffusion
Keywords: CAO; chronic airway obstruction; CAT; COPD Assessment Test; CB; chronic bronchitis; COPDGene; COPD Gene Cohort; GOLD; Global Initiative for Chronic Obstructive Lung Disease; LSC; Lovelace Smokers' Cohort; QOL; quality of life; SF-36; 36-Item Short Form
Keywords: CTEPH; chronic thromboembolic pulmonary hypertension; PH; pulmonary hypertension; PEA; pulmonary endarterectomy; PAH; pulmonary arterial hypertension; BPA; balloon pulmonary angioplasty; QOL; quality of life; WHO; World Health Organization; 6MWD; 6-minute
Keywords: 6MWT; 6-min walk test; AZLI; aztreonam for inhalation solution; CF; cystic fibrosis; CFQ-R; Cystic Fibrosis Questionnaire-Revised; HRCT; high-resolution CT; PRO; patient-reported outcome; QOL-B; Quality of Life-Bronchiectasis; SGRQ; St. George's Respirato
Keywords: Exercise; Muscles; Pulmonary disease; chronic obstructive; Rehabilitation; BMI; body mass index; COPD; chronic obstructive pulmonary disease; FEV1; forced expiratory volume in 1 second; FFM; fat-free mass; FVC; forced vital capacity; HRQOL; health-related
Keywords: clustering; COPD; COPD disease progression; emphysema distribution; machine learning; COPDGene; Genetic Epidemiology of COPD; GOLD; Global Initiative for Chronic Obstructive Lung Disease; GWAS; genome-wide association studies; HU; Hounsfield units; MMRC;
GOLD Staging System is Appropriate to Predict Mortality in Older People With Chronic Obstructive Pulmonary Disease
Keywords: BODE index; Body-Mass Index, Airow Obstruction, Dyspnea, and Exercise Capacity Index; COPD; chronic obstructive pulmonary disease; ERS; European Respiratory Society; FEV1; Forced Expiratory Volume in 1 second; FEV1/Ht2; FEV1 divided by height squared; FEV
Physical activity in daily life in patients with idiopathic pulmonary fibrosis
Keywords: AEE; activity energy expenditure; BDI; Baseline Dyspnea Index; BMI; body mass index; COPD; chronic obstructive pulmonary disease; DLco; diffusing capacity of carbon monoxide; FEV1; forced expiratory flow in 1Â s; fIIP; fibrotic idiopathic interstitial pne
Relationship of Absolute Telomere Length With Quality of Life, Exacerbations, and Mortality in COPD
Keywords: COPD; exacerbation; mortality; quality of life; telomere; aTL; absolute telomere length; HR; hazard ratio; MACRO; Macrolide Azithromycin for Prevention of Exacerbations of COPD; SGRQ; St. George's Respiratory Questionnaire;
Cerebral oxygen availability during exercise in COPD patients with cognitive impairment
Keywords: ACE-R; Addenbrooke's cognitive examination-revised; BMI; body mass index; CAT; COPD assessment test; CBF; cerebral blood flow; CHV; cerebral haemoglobin volume; CET; cycle endurance test; CI; cognitive impaired; CN; cognitive normal; COPD; chronic obstr
Tai Chi and Pulmonary Rehabilitation Compared for Treatment-Naive Patients With COPD
Keywords: COPD; indacaterol; pulmonary rehabilitation; Tai Chi; 6MWD; 6-min walk distance; MCID; minimal clinically important difference; mMRC; modified Medical Research Council dyspnea score; PR; pulmonary rehabilitation; SGRQ; St. George's Respiratory Questionn
Treatment with long acting muscarinic antagonists stimulates serum levels of irisin in patients with COPD
Keywords: Chronic obstructive pulmonary disease (COPD); Irisin; Long acting muscarinic receptor antagonist (LAMA); Anticholinergics; 6MWD; 6-min walking-distance; COPD; chronic obstructive pulmonary disease; LAMA; long acting muscarinic antagonists; FNDC5; fibronec
Correlations between FEV1 and patient-reported outcomes: A pooled analysis of 23 clinical trials in patients with chronic obstructive pulmonary disease
Keywords: COPD; PROs; FEV1; TDI; SGRQ; Regression modelling;
β-Blockers in COPD
Keywords: β-blockers; COPD; lung function; safety; AE; adverse event; GOLD; Global Initiative for Chronic Obstructive Lung Disease; SGRQ; St. George's Respiratory Questionnaire;
Effect of a short term pulmonary rehabilitation programme on exercise capacity, pulmonary function and health related quality of life in patients with COPD
Keywords: COPD; Exercise capacity; Pulmonary function; Pulmonary rehabilitation programme; Quality of life; SGRQ;
Characteristics of patients with increasing COPD assessment test scores within 3 years
Keywords: COPD; Emphysema; Quality of life; COPD; chronic obstructive pulmonary disease; CAT; COPD assessment test; ÎCAT; rate of change in CAT; SGRQ; St. George's Respiratory Questionnaire; ÎSGRQ; rate of change in SGRQ; FEV1; forced expiratory volume in one sec
Clinical and Genetic Associations of Objectively Identified Interstitial Changes in Smokers
Keywords: CT scanning; emphysema; interstitial lung abnormalities; mortality; pulmonary fibrosis; COPDGene; Genetic Epidemiology of COPD; ILA; interstitial lung abnormality; ILD; interstitial lung disease; IPF; idiopathic pulmonary fibrosis; MUC5B; mucin 5B; SGRQ;
Development and Initial Validation of a Questionnaire to Measure Health-Related Quality of Life of Adults with Common Variable Immune Deficiency: The CVID_QoL Questionnaire
Keywords: Burden of disease; Common variable immune deficiency; CVID_QoL; Disease-specific questionnaire; Quality of life; Questionnaire validation; BMI; Body mass index; CVID; Common variable immune deficiency; EF; Emotional functioning; EQ-5D; EuroQol-5 dimension
A Randomized Controlled Trial of Atorvastatin in Patients With Bronchiectasis Infected With Pseudomonas Aeruginosa
Keywords: infection; inflammation; microbiology; CRP; C-reactive protein; fMLF; formyl-methionyl-leucyl phenylalanine; LCQ; Leicester Cough Questionnaire; SGRQ; St. George's Respiratory Questionnaire;
Obesity Is Associated With Increased Morbidity in Moderate to Severe COPD
Keywords: COPD; dose response; exacerbation; morbidity; obesity; 6MWD; 6-min walk distance; AECOPD; acute exacerbation of COPD; COPDGene; Genetic Epidemiology of COPD; GOLD; Global Initiative for Chronic Obstructive Lung Disease; MCID; minimum clinically important
Effect of pulmonary rehabilitation on tidal expiratory flow limitation at rest and during exercise in COPD patients
Keywords: COPD; chronic obstructive pulmonary disease; DH; dynamic hyperinflation; DLCO; diffusing capacity of the lung for carbon monoxide; EELV; end-expiratory lung volume; NFL; non-expiratory flow limitation during tidal breathing; EFL; expiratory flow limitatio
The RESPIRE trials: Two phase III, randomized, multicentre, placebo-controlled trials of Ciprofloxacin Dry Powder for Inhalation (Ciprofloxacin DPI) in non-cystic fibrosis bronchiectasis
Keywords: CF; cystic fibrosis; COPD; chronic obstructive pulmonary disease; DPI; dry powder for inhalation; EOS; end of study; EOT; end of treatment; FAS; full analysis set; FEV1; forced expiratory volume in 1Â s; FVC; forced vital capacity; MIC; minimum inhibitory
Baseline Symptom Score Impact on Benefits of Glycopyrrolate/Formoterol Metered Dose Inhaler in COPD
Keywords: bronchodilators; chronic bronchitis; combination therapy; emphysema; metered dose inhalers; CAT; COPD Assessment Test; FF; formoterol fumarate; GFF; glycopyrrolate/formoterol fumarate; GOLD; Global Initiative for Chronic Obstructive Lung Disease; GP; glyc
Efficacy and Safety of Glycopyrrolate/Formoterol Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Patients With COPD
Keywords: β2-agonist; bronchodilator; chronic bronchitis; emphysema; muscarinic antagonists; AE; adverse event; ATS; American Thoracic Society; CAT; COPD Assessment Test; DPI; dry powder inhaler; FDC; fixed-dose combination; FEV1 AUC0-12; FEV1 area under the curv
Development of a dyspnoea word cue set for studies of emotional processing in COPD
Keywords: CES-D; center for epidemiological studies depression questionnaire; COPD; chronic obstructive pulmonary disease; FMRI; functional magnetic resonance imaging; MRI; magnetic resonance imaging; SD; standard deviation; SGRQ; St. George respiratory questionnai
Fifteen-year mortality of patients with asthma-COPD overlap syndrome
Keywords: 6MWT; 6-min walking test; ACOS; asthma-COPD overlap syndrome; BD; bronchodilator; COPD; chronic obstructive pulmonary disease; GLI; Global Lung Initiative; HRQL; health-related quality of life; LLN; lower limit of normal; PY; person/years; SA.R.A.; SAlu
Efficacy and safety of indacaterol/glycopyrronium in Japanese patients with COPD: Pooled analysis of SHINE and ARISE
Keywords: AE; adverse event; CCV; cerebro-cardiovascular; CI; confidence interval; DPI; dry powder inhaler; ECG; electrocardiography; FEV1; forced expiratory volume in one second; FVC; forced vital capacity; GOLD; Global Initiative for Chronic Obstructive Lung Dise
Sequential Bilateral Bronchoscopic Lung Volume Reduction With One-Way Valves for Heterogeneous Emphysema
Keywords: BLVR; bronchoscopic lung volume reduction; EBV; endobronchial valve; FEV1; forced expiratory volume in 1 second; FVC; forced vital capacity; HRCT; high-resolution computed tomography; LVRS; lung volume reduction surgery; RV; residual volume; SGRQ; St. Geo
Age-Related Differences in Health-Related Quality of Life in COPD
Keywords: aging; COPD; dyspnea; geriatrics; health status; obstructive lung disease; quality of life; COPDGene; Genetic Epidemiology of COPD; GOLD; Global Initiative for Chronic Obstructive Lung Disease; HRQL; health-related quality of life; mMRC; modified Medical
The COPD Assessment Test
Keywords: COPD; health-related quality of life; patient-reported outcome; CanCOLD; Canadian Cohort Obstructive Lung Disease; CAT; COPD Assessment Test; GOLD; Global Initiative for Chronic Obstructive Lung Disease; mMRC; modified British Medical Research Council dys
Long-term Course of Depression Trajectories in Patients With COPD
Keywords: COPD; depression; dyspnea; long-term follow-up; new onset; persistent; remittent; 6MWD; 6-min walk distance; CCL18; chemokine (C-C motif) ligand 18; CES-D; Center for Epidemiologic Studies Depression Scale; CRP; C-reactive protein; ECLIPSE; Evaluation of
A Novel Spirometric Measure Identifies Mild COPD Unidentified by Standard Criteria
Keywords: airway obstruction; COPD; spirometry; thoracic radiology; 6MWD; 6-min walking distance; BODE; BMI, airflow obstruction, dyspnea, and exercise; COPDGene; Genetic Epidemiology of COPD; E/I MLA; expiratory to inspiratory ratio of mean lung attenuation; FEV3;
The overall impact of COPD (CAT) and BODE index on COPD male patients: correlation?
Keywords: BMI; body mass index; BODE; body mass index, airflow limitation (forced expiratory volume in one second), dyspnoea and 6-min walk distance; FEV1; forced expiratory volume in one second; CAT; COPD assessment Test; CCQ; Clinical COPD questionnnaire; COPD; c
The Relationship of the Fibrinogen Cleavage Biomarker Aa-Val360 With Disease Severity and Activity in α1-Antitrypsin Deficiency
Keywords: AAT; α1-rantitrypsin; AATD; α1-cantitrypsin deficiency; CAT; COPD assessment tool; IQR; interquartile range; Kco; transfer coefficient; LABA; long-acting à agonist; NE; neutrophil elastase; SGRQ; St. George's Respiratory Questionnaire;
Tiotropium + olodaterol shows clinically meaningful improvements in quality of life
Keywords: COPD; Quality of life; Long-acting bronchodilator; Tiotropium; Olodaterol; AE; adverse event; AUC0-3; area under the curve from 0 to 3Â h; COPD; chronic obstructive pulmonary disease; FEV1; forced expiratory volume in 1Â s; GOLD; Global initiative for c
Relapse in FEV1 Decline After Steroid Withdrawal in COPD
Keywords: AHR; airway hyperresponsiveness; CCQ; Clinical COPD Questionnaire; F6; 6-month treatment with fluticasone; F30; 30-month treatment with fluticasone; FS30; 30-month treatment with fluticasone and salmeterol; GL1; first part of the Groningen and Leiden Univ
Efficacy and safety of umeclidinium added to fluticasone furoate/vilanterol in chronic obstructive pulmonary disease: Results of two randomized studies
Keywords: Long-acting muscarinic antagonist; Inhaled corticosteroid; Long-acting beta2 agonist; Bronchodilation; AE; adverse event; ASE; all subjects enrolled; CAT; COPD Assessment Test; CI; confidence interval; COPD; chronic obstructive pulmonary disease; FEV1; fo
How Common Is Airflow Limitation in Patients With Emphysema on CT Scan of the Chest?
Keywords: AWT; airway wall thickness; GOLD; Global Initiative for Chronic Obstructive Lung Disease; LAA; low attenuation area; LLN; lower limit of normal; SGRQ; St. George's Respiratory Questionnaire;
Association Between Pathogens Detected Using Quantitative Polymerase Chain Reaction With Airway Inflammation in COPD at Stable State and Exacerbations
Keywords: CFU; colony-forming units; PPM; potentially pathogenic microorganism; qPCR; quantitative polymerase chain reaction; SGRQ; St. George's Respiratory Questionnaire; TNF; tumor necrosis factor; VAS; visual analog scale;
Differential Effect of Modified Medical Research Council Dyspnea, COPD Assessment Test, and Clinical COPD Questionnaire for Symptoms Evaluation Within the New GOLD Staging and Mortality in COPD
Keywords: 6MWD; 6-min walk distance; BODE; BMI, measure of airflow obstruction, dyspnea score, and exercise capacity; CAT; COPD Assessment Test; CCQ; Clinical COPD Questionnaire; CHAIN; COPD History Assessment in Spain; GOLD; Global Initiative for Chronic Obstructi
Idiopathic pulmonary fibrosis: Recent advances on pharmacological therapy
Keywords: Clinical trials; Idiopathic pulmonary fibrosis; Nintedanib; Pirfenidone; Therapy; Treatment; AE; acute exacerbation; AEC; alveolar epithelial cell; ANCOVA; analysis of covariance; DLCO; diffusing capacity of the lung for carbon monoxide; DPLD; diffuse par